B
10.84
-0.73 (-6.31%)
| Penutupan Terdahulu | 11.57 |
| Buka | 11.19 |
| Jumlah Dagangan | 443,112 |
| Purata Dagangan (3B) | 817,757 |
| Modal Pasaran | 630,984,512 |
| Harga / Buku (P/B) | 1.13 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 May 2025 |
| EPS Cair (TTM) | -1.69 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.13% |
| Nisbah Semasa (MRQ) | 24.62 |
| Aliran Tunai Operasi (OCF TTM) | -88.27 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -53.72 M |
| Pulangan Atas Aset (ROA TTM) | -13.84% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.26% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | Bicara Therapeutics Inc. | Menurun | - |
AISkor Stockmoo
0.0
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.00 |
|
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 11.65% |
| % Dimiliki oleh Institusi | 89.28% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 41.00 (HC Wainwright & Co., 278.23%) | Beli |
| Median | 24.50 (126.02%) | |
| Rendah | 8.00 (Wells Fargo, -26.20%) | Pegang |
| Purata | 24.50 (126.02%) | |
| Jumlah | 1 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 11.87 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wells Fargo | 23 May 2025 | 8.00 (-26.20%) | Pegang | 9.27 |
| 17 Apr 2025 | 8.00 (-26.20%) | Jual | 12.16 | |
| HC Wainwright & Co. | 16 May 2025 | 41.00 (278.23%) | Beli | 14.47 |
| 07 Apr 2025 | 44.00 (305.90%) | Beli | 9.51 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| MEISNER LARA | - | 10.00 | -15,829 | -158,290 |
| Jumlah Keseluruhan Kuantiti Bersih | -15,829 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -158,290 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 10.00 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| MEISNER LARA | Pegawai | 16 Jun 2025 | Jual automatik (-) | 15,829 | 10.00 | 158,290 |
| MEISNER LARA | Pegawai | 16 Jun 2025 | Pelaksanaan pilihan | 15,829 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |